Medicare Enrolled
Dr. David Harnick, M.D.
Cardiovascular Disease · New York, NY
Practice pattern: Remote Monitoring
— Significant remote device monitoring activity
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Harnick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harnick?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harnick
Dr. David Harnick is a cardiovascular disease specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Harnick performed 9,645 Medicare services across 3,266 unique beneficiaries.
Between the years covered by Open Payments, Dr. Harnick received a total of $188,233 from 42 pharmaceutical and/or device companies across 1009 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harnick is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in NY
$188,233 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,645
Medicare services
Top 3% in NY for cardiovascular disease
3,266
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~508 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
1,781 | $64 | $450 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
1,363 | $22 | $200 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
807 | $34 | $350 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
529 | $53 | $72 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
525 | $42 | $250 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
423 | $22 | $300 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
420 | $44 | $300 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
395 | $12 | $145 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
380 | $74 | $247 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
364 | $25 | $200 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
358 | $20 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
347 | $106 | $339 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
322 | $75 | $250 |
| Cardiac rhythm monitor programming Adjustment and configuration of an implanted cardiac rhythm monitoring device to ensure proper operation and data collection. |
226 | $50 | $200 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
217 | $67 | $330 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
197 | $107 | $348 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
134 | $155 | $1,497 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
94 | $152 | $491 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
93 | $46 | $150 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
66 | $46 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
62 | $135 | $591 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
61 | $8 | $150 |
| Heart muscle strain imaging | 60 | $33 | $80 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
45 | $3,980 | $11,250 |
| New patient office visit, complex (60-74 min) | 37 | $174 | $737 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
34 | $86 | $456 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
33 | $84 | $400 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $150 | $550 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
26 | $236 | $477 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
22 | $11 | $55 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
22 | $20 | $100 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
22 | $58 | $250 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
20 | $68 | $350 |
| Removal of subcutaneous heart rhythm monitor This procedure involves the removal of a heart rhythm monitor that has been implanted under the skin. It is a minor surgical intervention to extract the device. |
19 | $121 | $5,868 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
19 | $55 | $458 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
18 | $22 | $289 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
18 | $765 | $1,607 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
17 | $94 | $1,441 |
| Pacemaker insertion with heart chamber electrodes A surgical procedure to implant a pacemaker device and place electrodes into the upper and lower chambers of the heart to regulate heart rhythm. |
15 | $454 | $2,387 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
15 | $21 | $50 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $84 | $305 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.2% high complexity
0.6% medium
87.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$188,233
Total received (2018-2024)
Avg $26,890/year across 7 years
Top 3% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
1,009
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$142,723 (75.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$37,574 (20.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,936 (4.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,511
2023
$9,005
2022
$50,409
2021
$47,637
2020
$27,642
2019
$22,991
2018
$23,038
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SANOFI-AVENTIS U.S. LLC
$5,213
Boehringer Ingelheim Pharmaceuticals, Inc.
$363
Lilly USA, LLC
$241
Boston Scientific Corporation
$203
AstraZeneca Pharmaceuticals LP
$203
Janssen Pharmaceuticals, Inc
$201
Esperion Therapeutics, Inc.
$196
Lexicon Pharmaceuticals, Inc.
$196
Medtronic, Inc.
$175
Merck Sharp & Dohme LLC
$147
Novartis Pharmaceuticals Corporation
$101
Bayer Healthcare Pharmaceuticals Inc.
$83
Actelion Pharmaceuticals US, Inc.
$55
Kowa Pharmaceuticals America, Inc.
$50
E.R. Squibb & Sons, L.L.C.
$35
Amgen Inc.
$28
Novo Nordisk Inc
$21
Top 3 companies account for 77.4% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$105,933
BIOTRONIK INC.
$27,525
Boehringer Ingelheim Pharmaceuticals, Inc.
$17,067
E.R. Squibb & Sons, L.L.C.
$5,251
Medtronic Vascular, Inc.
$4,224
Lexicon Pharmaceuticals, Inc.
$4,158
Aziyo Biologics, Inc.
$3,846
Edwards Lifesciences Corporation
$3,500
Janssen Pharmaceuticals, Inc
$2,342
Abbott Laboratories
$1,620
Novartis Pharmaceuticals Corporation
$1,615
AstraZeneca Pharmaceuticals LP
$1,361
Esperion Therapeutics, Inc.
$1,209
Amgen Inc.
$946
Boston Scientific Corporation
$863
PFIZER INC.
$775
Medtronic, Inc.
$750
Novo Nordisk Inc
$667
Lilly USA, LLC
$578
Kowa Pharmaceuticals America, Inc.
$561
Amarin Pharma Inc.
$543
Lundbeck LLC
$542
Merck Sharp & Dohme LLC
$355
Actelion Pharmaceuticals US, Inc.
$311
ARBOR PHARMACEUTICALS, INC.
$256
Vifor Pharma, Inc.
$232
Regeneron Healthcare Solutions, Inc.
$170
Bayer Healthcare Pharmaceuticals Inc.
$163
G Medical Diagnostic Services, Inc.
$161
Alnylam Pharmaceuticals Inc.
$159
Relypsa, Inc.
$122
Akcea Therapeutics, Inc.
$82
BOSTON SCIENTIFIC CORPORATION
$82
Arbor Pharmaceuticals, Inc.
$53
Bardy Diagnostics, Inc.
$51
Inspire Medical Systems, Inc.
$36
Daiichi Sankyo Inc.
$24
Merck Sharp & Dohme Corporation
$23
AbbVie Inc.
$21
Astellas Pharma US Inc
$20
Althera Pharmaceuticals LLC
$19
Philips Electronics North America Corporation
$17
Top 3 companies account for 80.0% of all-time payments
Associated products mentioned in payments ›
(5050) Ext Holter · AMPLATZER · AMPLATZER AMULET · AMPLATZER Occluders · Acticor · Acticor 7 VR-T DX · Agilis NxT EP Introducer · Arctic Front · BIOMONITOR · BRILINTA · Bidil · BioMonitor · BioMonitor 2 · CAMZYOS · CHANTIX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · CardioMEMS HF System · CareLink · Carnation Ambulatory Monitor · Cobalt · Corlanor · ECM · ECM Patch · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Edora · Ensite Cardiac Mapping System · FARXIGA · INJECTAFER · INSPIRE · INVOKANA · Inpefa · JARDIANCE · Kerendia · LEQVIO · LINQ II · LIVALO · LUX-Dx Insertable Cardiac Monitor · Livalo · MITRACLIP · MOUNJARO · MULTAQ · MYRBETRIQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PRADAXA · PRALUENT · PULSESELECT · Pouch · QUADRA ASSURA · REVEAL LINQ · Repatha · Reveal LINQ · Rivacor · Rivacor 7 DR-T · Roszet · SYMPLICITY G3 · SYNTHROID · Solia · TEGSEDI · TRULICITY · UPTRAVI · VERQUVO · VIAGRA · VYNDAMAX · VYNDAQEL · Vascepa · Veltassa · WAINUA · WATCHMAN · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for cardiovascular disease in NY.
Geographic Context
Cardiologists within 10 mi
1,842
Per 100K population
113.2
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Harnick is a remote monitoring specialist, with above-average Medicare volume (top 3% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Harnick experienced with remote monitoring of implantable heart rhythm device?
Based on Medicare claims data, Dr. Harnick performed 1,781 remote monitoring of implantable heart rhythm device services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harnick receive payments from pharmaceutical companies?
Yes. Dr. Harnick received a total of $188,233 from 42 companies across 1,009 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harnick's costs compare to other cardiologists in New York?
Dr. Harnick's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harnick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in New York
Browse cardiologists in New York ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology